Alta DiagnoTech

Alta DiagnoTech

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10M

Overview

Alta DiagnoTech operates as a diversified IVD player, offering products and services across the entire diagnostic value chain. Its portfolio is organized by technology (Molecular, Immuno, Biochemical, POCT), disease area (Infectious Disease, Cancer, Cardiovascular, etc.), and product type (Kits, Reagents, Instruments, Consumables). A key strategic pillar is its OEM and custom development service, providing end-to-end solutions from product development to manufacturing for client brands. The company serves both the clinical diagnostics market and the research community with 'Research Use Only' (RUO) products.

Infectious DiseasesOncologyCardiovascular DiseasesMetabolic DiseasesAutoimmune DiseasesGenetic DiseasesEndocrine DiseasesBlood-Related DiseasesFertility

Technology Platform

Provides a comprehensive suite of established in vitro diagnostic technologies including Molecular Diagnostics (PCR, Sequencing), Immunodiagnostics (ELISA, Chemiluminescence), Biochemical Diagnostics, and Point-of-Care Testing (POCT), coupled with full-service OEM and custom kit development capabilities.

Funding History

2
Total raised:$10M
Series A$8M
Seed$2M

Opportunities

Growth is driven by the expanding global IVD market, particularly in molecular diagnostics for oncology and infectious diseases, the rising demand for decentralized point-of-care testing, and the increasing trend of outsourcing through its full-service OEM and custom kit development platform.

Risk Factors

Key risks include intense competition from large, established IVD companies, regulatory hurdles across different global markets, dependence on a complex supply chain for raw materials, and the potential for technological disruption in the fast-evolving diagnostics field.

Competitive Landscape

Competes with broad-line giants (Roche, Abbott, Siemens) and specialized firms (Qiagen, Bio-Rad) across IVD segments. Differentiates through an extensive product matrix across all major diagnostic technologies and a strong emphasis on integrated OEM and custom development services for client brands.